恢复线粒体以恢复思想:在帕金森病中基于干细胞的生物能量救援
Supriya Shidhaye1, Anis Ahmad Chaudhary2, Mayuri Gajghate1
1Department of Quality Assurance, Smt. Kishoritai Bhoyar College of Pharmacy, Nagpur, India.
Neurodegenerative disease management
|September 19, 2025
概括
线粒体增强干细胞疗法在帕金森病中表现有前途,通过向受损神经元输送功能性线粒体. 这种方法旨在恢复细胞能量并改善运动功能,提供潜在的疾病修饰治疗.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
背景情况:
- 帕金森病涉及多巴氨基神经元退化和中央线粒体功能障碍.
- 目前的帕金森病治疗是症状性的,不能阻止疾病的进展.
研究的目的:
- 探索线粒体增强干细胞治疗作为帕金森病的疾病修饰策略.
- 研究工程干细胞提供功能性线粒体到神经元的潜力.
主要方法:
- 工程介质干细胞 (MSC) 和诱导多能干细胞 (iPSC) 来增强线粒体功能和转移.
- 利用基因操纵和预先条件的协议来增强干细胞.
- 通过道化纳米管和细胞外囊泡研究线粒体转移.
主要成果:
- 工程干细胞为受损的神经元提供功能性线粒体,增强ATP的产生.
- 这种疗法抑制了活性氧物种并恢复了线粒.
- 临床前模型显示神经元存活率和运动功能的改善.
结论:
- 线粒体增强干细胞疗法提供了一种新的机制来纠正帕金森病中的生物能量缺陷.
- 这种方法具有超越症状缓解的疾病修饰的潜力.
- 像CRISPR和3D生物打印等新兴技术提高了翻译相关性.
更多相关视频
12:13Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
Published on: July 11, 2019
7.6K
06:09Flow Cytometric Analysis of Multiple Mitochondrial Parameters in Human Induced Pluripotent Stem Cells and Their Neural and Glial Derivatives
Published on: November 8, 2021
5.0K
相关概念视频
Parkinson's Disease: Treatment
987
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
987
EPS and iPS Cells in Disease Research
3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
